These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 4210148

  • 1. Uptake of glibornuride by microdissected pancreatic islets.
    Täljedal IB.
    Horm Res; 1974; 5(4):211-6. PubMed ID: 4210148
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide)].
    Loubatières A, Ribes G, Mariani MM, Alric R.
    Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200420
    [No Abstract] [Full Text] [Related]

  • 4. Factors affecting the uptake of glibenclamide in microdissected pancreatic islets rich in beta-cells.
    Hellman B.
    Pharmacology; 1974; 11(5):257-67. PubMed ID: 4212009
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Extrapancreatic effects of sulfonylurea compounds. IV. Increase of the effect of insulin due to tolbutamide, glibornuride, and glibenclamide in vitro].
    Beyer J, Gather W, Schöffling K.
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2179. PubMed ID: 4198966
    [No Abstract] [Full Text] [Related]

  • 7. Dynamics of sulfonylurea-induced insulin release from the isolated perfused rat pancreas.
    Gotfredsen CF.
    Diabetologia; 1976 Aug; 12(4):339-42. PubMed ID: 134920
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Inhibition of K+ channels and stimulation of insulin secretion by the sulfonylurea, glimepiride, in relation to its membrane binding in pancreatic islets.
    Schwanstecher M, Mnner K, Panten U.
    Pharmacology; 1994 Aug; 49(2):105-11. PubMed ID: 7972319
    [Abstract] [Full Text] [Related]

  • 10. [Effect of a new sulfonylurea on insulin and glucagon secretion in the isolated perfused pancreas].
    Laube H, Fussgänger RD, Schröder KE, Pfeiffer EF.
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2186. PubMed ID: 4579624
    [No Abstract] [Full Text] [Related]

  • 11. The cAMP sensor Epac2 is a direct target of antidiabetic sulfonylurea drugs.
    Zhang CL, Katoh M, Shibasaki T, Minami K, Sunaga Y, Takahashi H, Yokoi N, Iwasaki M, Miki T, Seino S.
    Science; 2009 Jul 31; 325(5940):607-10. PubMed ID: 19644119
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Glucose modulates the amount, but not the kinetics, of insulin released by sulfonylureas.
    Gregorio F, Ambrosi F, Filipponi P, Cristallini S, Santeusanio F.
    J Diabetes Complications; 1994 Jul 31; 8(4):204-12. PubMed ID: 7833495
    [Abstract] [Full Text] [Related]

  • 14. [Current concepts of the pancreatic and extrapancreatic mechanisms of the action of peroral hypoglycemic sulfonylurea preparations].
    Poltorak VV, Gladkikh AI.
    Probl Endokrinol (Mosk); 1985 Jul 31; 31(2):76-85. PubMed ID: 2859589
    [No Abstract] [Full Text] [Related]

  • 15. Therapeutical concentrations of tolbutamide, glibenclamide, gliclazide and gliquidone at different glucose levels: in vitro effects on pancreatic A- and B-cell function.
    Gregorio F, Ambrosi F, Cristallini S, Pedetti M, Filipponi P, Santeusanio F.
    Diabetes Res Clin Pract; 1992 Dec 31; 18(3):197-206. PubMed ID: 1289021
    [Abstract] [Full Text] [Related]

  • 16. [Thyroid gland function of patients with diabetes in long-term use of glibornuride].
    Reinwein D.
    Arzneimittelforschung; 1972 Dec 31; 22():Suppl 12A:2221. PubMed ID: 4125093
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [The effect of oral antidiabetics on the biosynthesis of proinsulin in the rat].
    Tjioe TO, Wacker A.
    Arzneimittelforschung; 1972 Nov 31; 22(11):1890-2. PubMed ID: 4633587
    [No Abstract] [Full Text] [Related]

  • 19. The effect of tolbutamide and glibenclamide on the incorporation of ( 3 H)leucine and on the conversion of proinsulin to insulin in isolated pancreatic islets.
    Schatz H, Maier V, Hinz M, Nierle C, Pfeiffer EF.
    FEBS Lett; 1972 Oct 01; 26(1):237-40. PubMed ID: 4629118
    [No Abstract] [Full Text] [Related]

  • 20. Exchange protein directly activated by cyclic AMP isoform 2 is not a direct target of sulfonylurea drugs.
    Tsalkova T, Gribenko AV, Cheng X.
    Assay Drug Dev Technol; 2011 Feb 01; 9(1):88-91. PubMed ID: 21133673
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.